Literature DB >> 9218438

Synergy between anions and farnesyldiphosphate competitive inhibitors of farnesyl:protein transferase.

J D Scholten1, K K Zimmerman, M G Oxender, D Leonard, J Sebolt-Leopold, R Gowan, D J Hupe.   

Abstract

Investigation of the comparative activities of various inhibitors of farnesyl:protein transferase (FPTase) has led to the observation that the presence of phosphate or pyrophosphate ions in the assay buffer increases the potency of farnesyl diphosphate (FPP) competitive inhibitors. In addition to exploring the phenomenon of phosphate synergy, we report here the effects of various other ions including sulfate, bicarbonate, and chloride on the inhibitory ability of three FPP competitive compounds: Cbz-His-Tyr-Ser(OBn)TrpNH2 (2), Cbz-HisTyr(OPO42-)-Ser(OBn)TrpNH2 (3), and alpha-hydroxyfarnesyl phosphonic acid (4). Detailed kinetic analysis of FPTase inhibition revealed a high degree of synergy for compound 2 and each of these ions. Phosphorylation of 2 to give 3 completely eliminated any ionic synergistic effect. Moreover, these ions have an antagonistic effect on the inhibitory potency of compound 4. The anions in the absence of inhibitor exhibit non-competitive inhibition with respect to FPP. These results suggest that phosphate, pyrophosphate, bicarbonate, sulfate, and chloride ions may be binding at the active site of both free enzyme and product-bound enzyme with normal substrates. These bound complexes increase the potency of FPP competitive inhibitors and mimic an enzyme:product form of the enzyme. None of the anions studied here proved to be synergistic with respect to inhibition of geranylgeranyl transferase I. These findings provide insight into the mechanism of action of FPP competitive inhibitors for FPTase and point to enzymatic differences between FPTase and geranylgeranyl transferase I that may facilitate the design of more potent and specific inhibitors for these therapeutically relevant target enzymes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218438     DOI: 10.1074/jbc.272.29.18077

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Analysis of the combined effect of two linear inhibitors on a single enzyme.

Authors:  J J Martinez-Irujo; M L Villahermosa; J Mercapide; J F Cabodevilla; E Santiago
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

Review 2.  Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.

Authors:  Wen Li; Feifei Li; Xia Zhang; Hui-Kuan Lin; Chuan Xu
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

Review 3.  Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization.

Authors:  Aleksandra Marchwicka; Daria Kamińska; Mohsen Monirialamdari; Katarzyna M Błażewska; Edyta Gendaszewska-Darmach
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

4.  Discovery of an Anion-Dependent Farnesyltransferase Inhibitor from a Phenotypic Screen.

Authors:  Marina Bukhtiyarova; Erica M Cook; Paula J Hancock; Alan W Hruza; Anthony W Shaw; Gregory C Adam; Richard J O Barnard; Philip M McKenna; M Katharine Holloway; Ian M Bell; Steve Carroll; Ivan Cornella-Taracido; Christopher D Cox; Peter S Kutchukian; David A Powell; Corey Strickland; B Wesley Trotter; Matthew Tudor; Scott Wolkenberg; Jing Li; David M Tellers
Journal:  ACS Med Chem Lett       Date:  2020-12-23       Impact factor: 4.345

5.  Computational modeling of interactions between multiple myeloma and the bone microenvironment.

Authors:  Yan Wang; Peter Pivonka; Pascal R Buenzli; David W Smith; Colin R Dunstan
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.